Related Experiment Video
Updated: Apr 17, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
One Substance, Multiple Assessments: How the Various European Environmental Risk Frameworks Affect the Outcome of
Alexandra Kroll1, Annette Aldrich2, Sandrine Andres3
1Swiss Centre for Applied Ecotoxicology, Dübendorf, Switzerland.
Abstract:
The European Union (EU) regulates chemicals to protect the environment, but different regulations apply depending on the intended use of the substances in question. Advances in chemical monitoring have revealed inconsistencies in environmental risk assessments, prompting the European Commission to advocate for a "one substance, one assessment" (OS-OA) approach. As part of the EU Partnership for the Assessment of the Risk from Chemicals (PARC), this study examines the implementation and outcome of environmental risk assessments carried out within different regulatory frameworks, focusing on the aquatic environment. Using case studies on imidacloprid and deltamethrin, we highlight methodological differences and their implications for OS-OA. Our analysis reveals little consistency in the data used by assessments in different regulatory processes. This is partially due to the historical development of risk assessments. In addition, we show that new scientific data are not consistently incorporated into risk assessments, leading to delays and prolonged environmental risks. Finally, we demonstrate that low analytical sensitivities contribute to low detection rates in monitoring programs and hinder comparisons between prospective and retrospective risk assessments. Differences in data accessibility and validity assessments and lack of collaboration and varying involvement of Member States contribute to these inconsistencies and underscore the need for standardized methods. As a result of different data requirements, models, and protection goals, isolated risk assessments of the same substance lead to divergent outcomes. In cases where data gaps exist and safe uses cannot be demonstrated, we strongly recommend read-across of hazard assessments between regulations to support more efficient regulatory conclusions. In summary, our findings highlight the need for coherent regulation and risk assessment to improve environmental protection in the EU.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Effects of Chemicals: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Framing Effects
Drug Regulation

